研究業績

2013年の業績

英文論文

  1. Hanawa F, Inozume T, Harada K, Andou N, Kawamura T, Shibagaki N, Shimada S  A case of dermatomyositis accompanied by spontaneous intramuscular hemorrhage despite normal coagulability. Rheumatol International 2013 33:2949-2950
  2. Matsuzawa T, Kawamura T, Ogawa Y, Takahashi M, Aoki R, Moriishi K, Koyanagi Y, Gatanaga H, Blauvelt A, Shimada S  Oral administration of the CCR5 inhibitor, maraviroc, blocks HIV ex vivo infection of Langerhans cells within the epithelium. J Invest Dermatol. 2013 133:2803-2805
  3. Aoki R, Kawamura T, Goshima F, Ogawa Y, Nakae S, Nakao A, Moriishi K, Nishiyama Y, Shimada S  Mast cells play a key role in host defense against herpes simplex virus infection through TNF-α and IL-6 production. J Invest Dermatol. 2013 133:2170-2179
  4. Harada K, Inozume T, Kawamura T, Shibagaki N, Kinoshita T, Deguchi N, Shimada S  Two cases of autosomal recessive woolly hair with LIPH gene mutations. Int J Dermatol. 2013 52:572-574
  5. Geng S, Matsushima H, Okamoto T, Yao Y, Lu R, Page K, Blumenthal RM, Ward NL, Miyazaki T, Takashima A  Emergence, origin, and function of neutrophil-dendritic cell hybrids in experimentally induced inflammatory lesions in mice. Blood. 2013 121:1690-1700
  6. Matsushima H, Geng S, Lu R, Okamoto T, Yao Y, Mayuzumi N, Kotol PF, Chojnacki BJ, Miyazaki T, Gallo RL, Takashima A  Neutrophil differentiation into a unique hybrid population exhibiting dual phenotype and functionality of neutrophils and dendritic cells. Blood. 2013 121:1677-1689
  7. Ogawa Y, Kawamura T, Matsuzawa T, Aoki R, Gee P, Yamashita A, Moriishi K, Yamasaki K, Koyanagi Y, Blauvelt A, Shimada SAntimicrobial peptide LL-37 produced by HSV-2-infected keratinocytes enhances HIV infection of Langerhans cells. Cell Host Microbe. 2013 13:77-86
  8. Iwamoto T, Ikeda K, Hosokawa J, Yamagata M, Tanaka S, Norimoto A, Sanayama Y, Nakagomi D, Takahashi K, Hirose K, Sugiyama T, Sueishi M, Nakajima H. Ultrasonographic assessment predicts relapse after discontinuation of biological agents in patients with rheumatoid arthritis in clinical remission. Arthritis Care Res (Hoboken). 2014 Feb 10. doi: 10.1002/acr.22303. [Epub ahead of print]
  9. Nakagomi D, Ikeda K, Okubo A, Iwamoto T, Sanayama Y, Takahashi K, Yamagata M, Takatori H, Suzuki K, Takabayashi K, Nakajima H. Ultrasound can improve the accuracy of the 2010 ACR/EULAR classification criteria for rheumatoid arthritis to predict methotrexate requirement. Arthritis Rheum. 2013;65(4):890-8.
  10. Nakagomi D, Suzuki K, Hosokawa J, Kobayashi Y, Suto A, Takatori H, Watanabe N, Matsue H, Murphy TL, Murphy KM, Shimada S, Nakajima H. Therapeutic Potential of B and T Lymphocyte Attenuator Expressed on CD8(+) T Cells for Contact Hypersensitivity. J Invest Dermatol. 2013;133(3):702-11.
  11. Nakagomi D, Ikeda K, Kawashima H, Kobayashi Y, Suto A, Nakajima H. Bucillamine-induced yellow nail in Japanese patients with rheumatoid arthritis: two case reports and a review of 36 reported cases. Rheumatol Int. 2013 Mar;33(3):793-7.
  12. Ikeda K, Sanayama Y, Makita S, Hosokawa J, Yamagata M, Nakagomi D, Takabayashi K, Nakajima H. Efficacy of Abatacept for Arthritis in Patients with an Overlap Syndrome between Rheumatoid Arthritis and Systemic Lupus Erythematosus. Clin Dev Immunol. 2013;2013:697525. doi: 10.1155/2013/697525. Epub 2013 Nov 14.
  13. Ikeda K, Nakagomi D, Sanayama Y, Yamagata M, Okubo A, Iwamoto T, Kawashima H, Takahashi K, Nakajima H. Correlation of radiographic progression with the cumulative activity of synovitis estimated by power Doppler ultrasound in rheumatoid arthritis: difference between patients treated with methotrexate and those treated with biological agents.J Rheumatol. 2013 Dec;40(12):1967-76.
  14. Ikeda K, Seto Y, Ohno S, Sakamoto F, Henmi M, Fukae J, Narita A, Nakagomi D, Nakajima H, Tanimura K, Koike T. Analysis of the factors influencing the measurement of synovial power Doppler signals with semi-quantitative and quantitative measures - a pilot multicenter exercise in Japan. Mod Rheumatol. 2013 Nov 5
  15. Tanaka S, Suto A, Ikeda K, Iwamoto T, Sanayama Y, Nakagomi D, Suzuki K, Nakajima H. Alteration of circulating microRNAs in SSc: microRNA-30b regulates the expression of PDGF receptor β. Rheumatology (Oxford). 2013 Nov;52(11):1963-72.
  16. Tanaka S, Ikeda K, Uchiyama K, Iwamoto T, Sanayama Y, Okubo A, Nakagomi D, Takahashi K, Yokota M, Suto A, Suzuki K, Nakajima H. [18F] FDG uptake in proximal muscles assessed by PET/CT reflects both global and local muscular inflammation and provides useful information in the management of patients with polymyositis/dermatomyositis. Rheumatology (Oxford). 2013 Jul;52(7):1271-8.
  17. Hosokawa J, Suzuki K, Nakagomi D, Tamachi T, Takatori H, Suto A, Nakajima H. Role of calcium ionophore A23187-induced activation of IkappaB kinase 2 in mast cells.Int Arch Allergy Immunol. 2013 161 Suppl 2:37-43.
  18. Ning H, Mitsui H, Wang CQ, Suarez-Farinas M, Gonzalez J, Shah KR, Chen J, Coats I, Felsen D, Carucci JA, Krueger JG  Identification of anaplastic lymphoma kinase as a potential therapeutic target in Basal Cell Carcinoma. Oncotarget.2013 4:2237-48
  19. Belkin DA, Chen J, Mo JL, Rosoff JS, Goldenberg S, Poppas DP, Krueger JG, Herschman M, Mitsui H, Felsen D, Carucci JA An animal explant model for the study of human cutaneous squamous cell carcinoma. PLoS One. 2013 8:e76156
  20. Wang CQ, Akalu YT, Suarez-Farinas M, Gonzalez J, Mitsui H, Lowes MA, Orlow SJ, Manga P, Krueger JG IL-17 and TNF synergistically modulate cytokine expression while suppressing melanogenesis: potential relevance to psoriasis. J Invest Dermatol. 2013 133:2741-52
  21. Gulati N, Krueger JG, Suarez-Farinas M, Mitsui H Creation of differentiation-specific genomic maps of human epidermis through laser capture microdissection. J Invest Dermatol. 2013 133:2640-2
  22. Zhang S, Fujita H, Mitsui H, Yanofsky VR, Fuentes-Duculan J, Pettersen JS, Suarez-Farinas M, Gonzalez J, Wang CQ, Krueger JG, Felsen D, Carucci JA Increased Tc22 and Treg/CD8 ratio contribute to aggressive growth of transplant associated squamous cell carcinoma. PLoS One. 2013 7:e62154.
  23. Yanofsky VR, Mitsui H, Felsen D, Carucci JA Understanding dendritic cells and their role in cutaneous carcinoma and cancer immunotherapy. Clin Dev Immunol.2013;2013:624123.
  24. Belkin DA, Mitsui H, Wang CQ, Gonzalez J, Zhang S, Shah KR, Coats I, Suarez-Farinas M, Krueger JG, Felsen D, Carucci JA CD200 upregulation in vascular endothelium surrounding cutaneous squamous cell carcinoma.JAMA Dermatol. 2013 149:178-86
  25. Belkin DA, Mitsui H, Wang CQ, Gonzalez J, Zhang S, Shah KR, Coats I, Suarez-Farinas M, Krueger JG, Felsen D, and Carucci JA. CD200 upregulation in vascular endothelium surrounding cutaneous squamous cell carcinoma. JAMA Dermatol. 2013 Feb; 149 (2), 178-186
  26. Yanofsky VR, Mitsui H, Felsen D, Carucci JA. Understanding Dendritic Cells and their Role in Cutaneous Carcinoma and Cancer Immunotherapy. 2013, Clin Dev Immunol, 2103, Article ID 624123
  27. Zhang S, Fujita H, Mitsui H, Fuentes-Duculan J, Yanofsky VR, Pettersen J, Suarez-Farinas M, Gonzalez J, Wang CQ, Krueger JG, Felsen D, Carucci JA. Increased Tc22 and T-reg/Tc ratio accelerate progression of transplant-associated SCC. PLoS ONE, 2013 May; 8 (5), e62154
  28. Gulati N, Krueger JG, Suarez-Farinas M, Mitsui H. Creation of differentiation-specific genomic maps of human epidermis through laser capture microdissection. J Invest Dermatol, 2013 Nov; 133 (11), 2640-2642
  29. Wang CQ, Akalu YT, Suarez-Farinas M, Gonzalez J, Mitsui H, Lowes MA, Orlow SJ, Manga P, Krueger JG. IL-17 and TNF synergistically modulate cytokine expression while suppressing melanogenesis: potential relevance to psoriasis. J Invest Dermatol, 2013 Dec; 133 (12), 2741-2752
  30. Belkin DA, Chen J, Mo JL, Rosoff J, Goldenberg S, Poppas D, Krueger JG, Herschman M, Mitsui H, Felsen D, and Carucci JA. An animal explant model for the study of human cutaneous squamous cell carcinoma. PLoS ONE, 2013 Oct; 8 (10), e76156
  31. Ning H, Mitsui H, Wang CQ, Suarez-Farinas M, Gonzalez J, Shah KR, Chen J, Israel C, Felsen D, Carucci JA, Krueger JG. Identification of anaplastic lymphoma kinase as a potential therapeutic target in Basal Cell Carcinoma. Oncotarget, 2013 Dec; 4 (12), 2237-2248
  32. Harada K, Yamaguchi M, Watanabe S, Shimada S  Onychogryphosis by an elastic wire. J Dermatol. 2013 40:1055-1056
  33. Geng S, Matsushima H, Okamoto T, Yao Y, Lu R, Takashima A  Reciprocal Regulation of Development of Neutrophil-Dendritic Cell Hybrids in Mice by IL-4 and Interferon-Gamma. PLoS One. 2013 8:1371

和文論文

  1. 松澤 美幸, 赤澤 聡, 安藤 典子, 猪爪 隆史, 原田 和俊, 川村 龍吉, 柴垣 直孝, 島田 眞路 外陰部に巨大な腫瘤を対称性に生じ,特異な臨床像を呈したMadelung病(良性対称性脂肪腫症)の1例 臨床皮膚科 67:883-886
  2. 山本 佐織, 渡辺 さゆり, 赤澤 聡, 安藤 典子, 原田 和俊, 川村 龍吉, 柴垣 直孝, 島田 眞路 血行性転移で死亡した外陰部偽腺性有棘細胞癌の1例 臨床皮膚科 67:707-711
  3. 山本 佐織, 原田 和俊, 安藤 典子, 青木 類, 川村 龍吉, 柴垣 直孝, 島田 眞路 DIHSの病態をとったテラプレビルによるTENの1例 日本皮膚科学会雑誌 123:149-154
  4. 高木 真知子, 渡辺 さゆり, 安藤 典子, 猪爪 隆史, 原田 和俊, 川村 龍吉, 柴垣 直孝, 島田 眞路 食道癌術後に発症した小麦依存性サリチル酸誘発性蕁麻疹の1例 臨床皮膚科 67:583-586
  5. 青木 類, 原田 和俊, 島田 眞路 【肉芽腫のすべて】 異物(薬剤、化学物質など)と肉芽腫 Derma 204:45-51
  6. 渡辺さゆり,赤澤 聡,安藤典子,原田和俊,川村龍吉,柴垣直孝,島田眞路 Pinkus型(Fibroepithelioma of Pinkus)と結節型が共存した基底細胞癌の1例 皮膚科の臨床 55:1247-1250
  7. 末木 侑希,川島 一郎, 三森 徹, 山本 健夫, 濱中 聡至, 野崎 由美, 中嶌 圭, 桐戸 敬太, 花輪 書絵, 島田 眞路, 井上 朋大, 中澤 匡男 Picture in Clinical Hematology ATRA内服中にSweet病を併発した急性前骨髄球性白血病 臨床血液54:261
  8. Ikeda K, Sanayama Y, Nakagomi D, Nakajima H. Evaluation of joint damage with conventional radiograph and synovitis with musculoskeletal ultrasonography in rheumatoid arthritis.日本臨牀 1185-92.

著書/総説

  1. 原田 和俊, 山口 美由紀, 島田 眞路 新・皮膚科セミナリウム 爪の診方と治し方 巻き爪と陥入爪の治療法 日本皮膚科学会雑誌 123:2069-2076
  2. 柴垣 直孝 【皮膚悪性腫瘍-基礎と臨床の最新研究動向-】 悪性黒色腫 悪性黒色腫の浸潤・転移 悪性黒色腫の浸潤、転移に関連する免疫系機序 日本臨床 71 皮膚悪性腫瘍:176-180
  3. 岡本 崇, 島田 眞路 【分子標的療法による炎症制御の現状と未来】 IL-12/23阻害剤ウステキヌマブ 別冊Bio Clinica慢性炎症と疾患 2 :101-106
  4. 猪爪 隆史 癌免疫療法臨床試験 最近の話題 日本臨床免疫学会会誌 36: 134-138
  5. 島田眞路 【臨床医学の展望2013 皮膚科学】 日本医事新報 4632:48-53
  6. 川村龍吉 ウイルス感染と免疫との関わり 病態、疫学から治療応用まで HIVの生体内侵入メカニズムと自然免疫との関わり 日本皮膚科学会雑誌123巻13号 2649-2651
  7. 川村龍吉 医学用語解説 LangerinとDC-SIGN 炎症と免疫21:176-177
  8. 川村龍吉【皮膚アレルギーの研究 アップデート~経皮感作とアレルギー~】 経皮感作のメカニズム アレルギー・免疫20:826-834
  9. 川村龍吉【最近のトピックス2013】 皮膚疾患の病態 腸性肢端皮膚炎の発症メカニズム 臨床皮膚科67:35-39
  10. 柴垣 直孝 がん免疫の最前線(臨床的立場、橋渡し的立場、基礎研究) 癌微小環境における免疫修飾/抑制状態の機序についてSkin Cancer 28:134-136